[Paroxysmal kinesigenic dyskinesia (PKD) a rare motion disorder].
Kuoppamäki
Mikko
M
Orion Pharma, kliininen tutkimus, Turku. mikko.kuoppamaki@orionpharma.com
Keränen
Tapani
T
D000328:Adult; D002220:Carbamazepine / Q000627:therapeutic use; D002819:Chorea / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D005387:Finland; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007473:Ion Channels / Q000503:physiopathology; D008297:Male; D010375:Pedigree; D035583:Rare Diseases; D012720:Severity of Illness Index; D016896:Treatment Outcome
D007473:Ion Channels; D002220:Carbamazepine